Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Single Nucleotide Polymorphisms-SNPs01:05

Single Nucleotide Polymorphisms-SNPs

17.4K
A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
17.4K
Sanger Sequencing01:57

Sanger Sequencing

767.1K
DNA sequencing is a fundamental technique that is routinely used in the biological sciences. This method can be applied to a range of questions at different scales - from the sequencing of a cloned DNA fragment or the study of a mutation in a gene up to whole-genome sequencing. However, despite the widespread use of sequencing today, it was not until 1977 that Fredrick Sanger and his collaborators developed the chain-termination method to decode DNA sequences. It relies on the separation of a...
767.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

<i>Cryptococcus neoformans</i> causing localised osteomyelitis of the right anterior rib.

BMJ case reports·2026
Same author

Longitudinal SARS-CoV-2 antibody response in a healthcare worker cohort utilising the Abbott Alinity® anti-nucleocapsid assay.

PloS one·2025
Same author

Health Care Personnel Workdays Lost and Direct Health Care Salary Costs Incurred due to COVID-19 Infection in the Age of Widespread Vaccine Availability.

The Journal of infectious diseases·2024
Same author

Investigating incidence of and factors associated with SARS-CoV-2 infection over a nine-month period in a highly-vaccinated healthcare worker cohort.

QJM : monthly journal of the Association of Physicians·2024
Same author

Distinct Inflammatory Phenotypes Are Associated With Subclinical and Clinical Cardiovascular Disease in People With Human Immunodeficiency Virus.

The Journal of infectious diseases·2024
Same author

Post-COVID care delivery: The experience from an Irish tertiary centre's post-COVID clinic.

PloS one·2023

Related Experiment Video

Updated: Nov 20, 2025

Quantification and Whole Genome Characterization of SARS-CoV-2 RNA in Wastewater and Air Samples
09:26

Quantification and Whole Genome Characterization of SARS-CoV-2 RNA in Wastewater and Air Samples

Published on: June 30, 2023

1.4K

Partial N Gene Sequencing for SARS-CoV-2 Verification and Pathway Tracing.

Sin Hang Lee1, Jonathan McGrath2, Stephen P Connolly2

  • 1Milford Molecular Diagnostics Laboratory, Milford, CT, USA.

International Medical Case Reports Journal
|January 20, 2021
PubMed
Summary

Sequencing SARS-CoV-2 (Severe Acute Respiratory Syndrome Coronavirus 2) nucleocapsid gene amplicons can confirm positive RT-qPCR results and track virus strains. This method helps reduce false positives, preventing unnecessary disruptions from inaccurate COVID-19 diagnoses.

Keywords:
COVID-19SARS-CoV-2 verificationSanger sequencingfalse-positivepartial N gene sequencingphylogenetically distinct strainssingle nucleotide mutationvirus strain tracing

More Related Videos

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease
09:34

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease

Published on: April 4, 2018

34.3K
Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens
09:33

Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens

Published on: August 25, 2023

1.4K

Related Experiment Videos

Last Updated: Nov 20, 2025

Quantification and Whole Genome Characterization of SARS-CoV-2 RNA in Wastewater and Air Samples
09:26

Quantification and Whole Genome Characterization of SARS-CoV-2 RNA in Wastewater and Air Samples

Published on: June 30, 2023

1.4K
Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease
09:34

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease

Published on: April 4, 2018

34.3K
Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens
09:33

Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens

Published on: August 25, 2023

1.4K

Area of Science:

  • Virology
  • Genetics
  • Public Health

Background:

  • Real-time quantitative polymerase chain reaction (RT-qPCR) tests for SARS-CoV-2 can yield false positives, especially during periods of low virus prevalence.
  • Accurate confirmation of positive results is crucial for effective disease management and preventing unnecessary public health measures.

Observation:

  • A case of mild COVID-19 was confirmed using partial sequencing of the SARS-CoV-2 nucleocapsid (N) gene.
  • The sequencing identified a specific mutation pattern (GGG-to-AAC) linked to strains originating in Continental Europe.
  • Re-testing reference samples revealed mutations, including one associated with New York state strains and a novel frameshift mutation.

Findings:

  • Partial N gene sequencing accurately verifies SARS-CoV-2 positive RT-qPCR results.
  • The method can differentiate between various SARS-CoV-2 strains, aiding in tracking virus transmission.
  • Identified mutations included known European and New York variants, as well as a novel insertion.

Implications:

  • Routine sequencing of RT-qPCR positive samples can significantly reduce false-positive diagnoses.
  • Minimizing false positives can prevent undue public anxiety and avoid unnecessary closures of schools and businesses.
  • This approach supports more reliable monitoring of SARS-CoV-2 strain movement and evolution.